Sunday, March 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Infectious Diseases

At the Top of the COVID-19 Research Agenda: Asymptomatic Spread and Long-Term Health Impacts

by Global Biodefense Staff
January 26, 2021
At the Top of the COVID-19 Research Agenda: Asymptomatic Spread and Long-Term Health Impacts

Delivery of vaccine to priority groups during the early rollout of COVID-19 Operation Warp Speed. Credit: Ricardo Reyes / WRMMC

A new research agenda developed by 40 leading experts in healthcare epidemiology and infectious diseases defines the critical areas of study to inform clinical practice, policy, and prevention strategies for COVID-19 and future pandemics.

“COVID-19 Research Agenda for Healthcare Epidemiology,” published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), identifies the gaps in the understanding of the epidemiology, transmission, and individual as well as public health consequences of viral diseases that were revealed through some of the worst phases of the COVID-19 pandemic.

“The emergence and rapid world-wide spread of severe acute respiratory syndromewe coronavirus 2 (SARS-CoV-2) has led to unprecedented loss of life and socio/economic disruption. The scientific community has risen to this challenge and published an enormous body of work over the past year informing our response to the pandemic and leading to evolving guidelines for treatment, testing, and prevention,” said Lona Mody, MD, an author of the research agenda. “Looking to the future, the community still has much to learn. We must be intentional with our approach to improve how we prevent and treat COVID-19 and other viral illnesses.”

The SHEA Research Committee assembled a working group of experts in the field of healthcare epidemiology to identify immediate research priorities in epidemiology, outbreak investigation, surveillance, isolation precaution practices, personal protective equipment, environmental contamination and disinfection, drug and supply shortages, antimicrobial stewardship, healthcare personnel occupational safety, and return to work policies. The thought leaders highlighted three critical research questions in each of these 10 areas.

Among the most pressing areas for research, include:

  • Understanding the spread of the virus through asymptomatic and pre-symptomatic patients infected with COVID-19.
  • Determining how risk factors impact disease severity, as well as understanding long-term cardiometabolic, respiratory, neurological, and psychological impacts of the virus.
  • Developing tools to identify outbreaks more rapidly in hospitals, nursing homes, and other healthcare settings leading to early interventions to curtail outbreaks.
  • Improving the understanding of personal protective equipment, or PPE, including socio-behavioral reasons for not following PPE guidance, as well as the continued need for PPE during and after the pandemic.

“This research agenda calls for translational studies from laboratory-based basic science research to well-designed, large-scale studies and health outcomes research,” said Deverick Anderson, MD, MPH, the senior author of the research agenda. “To undertake this work, funding organizations must make COVID-19 research their highest priority.”

The authors note that this research agenda, while a significant tool for shaping the direction of the scientific literature, represents expert opinion at a moment in time during the worst days of the COVID-19 pandemic. They note that priorities may shift as the pandemic evolves and as vaccines and other therapeutics become available.

COVID-19 Research Agenda for Healthcare Epidemiology. Infection Control & Hospital Epidemiology, 25 January 2021.

Tags: COVID CountermeasuresCOVID-19Editor PickEpidemiologySARS-CoV-2Transmission Dynamics

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Officials Declare End to Ebola Outbreak in Uganda
Infectious Diseases

Officials Declare End to Ebola Outbreak in Uganda

January 11, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy